Reshaping The Pharmaceutical Supply Chain - Contract Pharma Q&A

March 04, 2021

While the COVID-19 vaccine rollouts are excellent news, they will impact the pharma and biopharma supply chain. Cryoport Systems CEO Mark Sawicki outlines what to expect the rest of the year in a new Contract Pharma article out this week. Sawicki discusses the expected effects on new clinical trial starts and biopharma distribution capabilities as well as anticipated approvals for new cell and gene therapies.

Read the full article here.

Questions or comments? We welcome your feedback!

Email Us

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC